AIEQ0.450%
as of Jul 20
TECH
GrowthBio-Techne Corp
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies.
Close · 3M
+30.56%
Held by 1 AI ETF
Signal performance
Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.
Buy signals5
Win rate100% (5/5)
Avg buy return+9.69%
AIEQ · New entry · 1d
weight 0 → 0.450% (new)·stock up 39.8% in the 30 days before
Jul 1·entry $71.00·now $71.64Fresh
+0.90%
since Jul 1
AIVL · Exit · 1d
TECH stock, currently trading at $70.65, sits at 99% of its 52-week high, following a substantial 30-day return of +59.0%. This rapid price appreciation likely propelled the company outside AIVL's pre-filtered US value-factor pool, which prioritizes stocks with genuine value characteristics. The AI's mandate to distinguish genuine value from value traps would have flagged TECH's elevated PER of 81.22 and PBR of 4.2, particularly when juxtaposed against its low revenue growth of 0.17% and ROE of 5.44%. Consequently, as the portfolio rebalanced on June 30, the company’s position was liquidated entirely, consistent with the AI’s assessment that its valuation no longer aligned with the fund's strict value and fundamental criteria.
weight 0.287% → 0 (exited)·stock up 36.7% in the 30 days before
Jun 30·entry $70.65·now $71.64
+1.40%
since Jun 30
AIVL · Accumulation · 6d
The observed gradual accumulation of Bio-Techne shares, marked by an acceleration towards the end of June, points to the WisdomTree AI's evolving assessment of the company. AIVL's methodology, which aims to distinguish genuine value from value traps using various fundamentals and valuation metrics, appears to have identified an underlying strength in TECH. This is notable given the company's P/E ratio of 81.22 and revenue growth of 0.17%, suggesting the AI's algorithm perceives a compelling value proposition through other factors such as margins, return on capital, or free cash flow yield. This increased allocation occurred even as the stock price approached its 52-week high after a 63.7% 30-day return, indicating the AI's model believes the intrinsic value of TECH is still increasing or was previously undervalued, justifying the purchases in a rising market for this value-factor fund.
weight 0.222% → 0.287% (+0.065 pp)·stock up 47.6% in the 30 days before
Jun 26·entry $71.00·now $71.64Fresh
+0.90%
since Jun 26
AIVL · Accumulation · 5d
AIVL's weight changes in TECH show a consistent, gradual accumulation from 0.22% to 0.28% over several trading days, culminating in a more pronounced increase towards the end of the period. This measured approach to building the position, even as TECH's stock price approached its 52-week high following a 58.7% 30-day return, indicates the WisdomTree AI system's sustained conviction. Despite TECH's current P/E ratio of 81.22 and modest 0.17% revenue growth, the AI's fundamental analysis, which considers metrics like margins, return on capital, and debt, likely continues to identify underlying value within its pre-filtered US value-factor universe. The AI is specifically programmed to distinguish authentic value from "value traps," suggesting it perceives specific company fundamentals, beyond just market price or P/E, as justifying this sustained allocation at the elevated price level.
weight 0.225% → 0.285% (+0.061 pp)·stock up 47.4% in the 30 days before
Jun 25·entry $70.70·now $71.64Fresh
+1.33%
since Jun 25
AIVL · Accumulation · 5d
WisdomTree's AIVL fund, which employs AI to score names within its approximately 100 US value stock portfolio, is gradually accumulating Bio-Techne Corp as part of its periodic rebalancing schedule. The AI’s mandate is to distinguish genuine value from value traps using a suite of fundamentals and valuation metrics that include margins, return on capital, and free cash flow yield, looking beyond just P/E and P/B ratios. Although TECH currently trades at a PER of 81.22, the AI's deeper analysis likely identified an underlying value proposition or a favorable long-term outlook not immediately apparent from headline ratios, especially considering the stock's prior position closer to its 52-week low. This continued accumulation, increasing the fund's weight in TECH from 0.2226% to 0.2415% over a two-week period, suggests sustained conviction despite the current price of $58.88, which reflects a +24.2% 30-day return.
weight 0.223% → 0.241% (+0.019 pp)·stock up 22.1% in the 30 days before
Jun 24·entry $58.88·now $71.64Chased
+21.67%
since Jun 24
AIVL · Weight increase · 2d
WisdomTree’s AIVL, leveraging AI to score names within its US value-factor pool, increased its allocation to Bio-Techne (TECH) through a series of consecutive adjustments, reaching 0.2377% by June 18th. These weight changes suggest the AI identified TECH as a genuine value opportunity within its roughly 100-stock portfolio, distinguishing it from potential value traps through its analysis of fundamentals like margins and return on capital. Despite the stock’s current P/E ratio of 83.59, the AI likely integrated a recent price rebound, evidenced by a +13.8% 30-day return, into its periodic rebalancing decision, signaling an improved score for TECH. This specific move indicates the AI perceived underlying strength or potential that outweighed traditional value metrics alone, aligning with its mandate to find mispriced assets.
weight 0.222% → 0.238% (+0.015 pp)·stock up 27.4% in the 30 days before
Jun 18·entry $57.94·now $71.64Chased
+23.65%
since Jun 18
AIVL · Weight decrease · 2d
The AI ETF likely initiated the consecutive weight decrease due to TECH's extremely high PER of 69.13 paired with stagnant revenue growth (0.17%) and low ROE (5.44%), signaling an overvalued asset with poor fundamental performance. Retail investors should take this as a warning to scrutinize high-valuation stocks that lack strong underlying growth and profitability, as even sophisticated AI models will divest from fundamentally weak holdings.
weight 0.218% → 0.202% (-0.017 pp)·stock down 14.6% in the 30 days before
May 11·entry $47.42·now $71.64
+51.08%
since May 11
AIVL · Weight decrease · 2d
The AI ETF likely reduced TECH's weight due to its extremely high PER and PBR, which are inconsistent with its very low revenue growth and ROE, indicating potential overvaluation and poor fundamental performance. This suggests the AI is rebalancing away from a stock exhibiting deteriorating value and efficiency metrics. For retail investors, this highlights the importance of scrutinizing fundamental metrics; high valuations unsupported by growth or profitability warrant careful consideration before investing.
weight 0.238% → 0.227% (-0.011 pp)·stock down 0.2% in the 30 days before
Apr 29·entry $51.95·now $71.64
+37.90%
since Apr 29
Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.